Lenox Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$18K Buy
49
+35
+250% +$11.7K 0.01% 362
2020
Q1
$3K Hold
14
﹤0.01% 567
2019
Q4
$5K Hold
14
﹤0.01% 545
2019
Q3
$4K Hold
14
﹤0.01% 567
2019
Q2
$4K Hold
14
﹤0.01% 543
2019
Q1
$4K Hold
14
﹤0.01% 547
2018
Q4
$3K Sell
14
-705
-98% -$165K ﹤0.01% 524
2018
Q3
$6K Buy
719
+705
+5,036% +$162K ﹤0.01% 484
2018
Q2
$3K Buy
+14
New +$2.97K ﹤0.01% 478
2017
Q4
Sell
-39
Closed -$7K 515
2017
Q3
$7K Hold
39
﹤0.01% 427
2017
Q2
$7K Buy
+39
New +$6.55K ﹤0.01% 405

Other funds holding TMO

Lenox Wealth Management's TMO Position: Q2 2020 in Review

Lenox Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 250% in Q2 2020, buying an estimated $11.7K and bringing the position to 49 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #362.

Lenox Wealth Management first reported a position in TMO in Q2 2017 and has held it in 11 quarters since. 1,748 funds tracked by Wall St. Rank hold TMO as of Q2 2020.

  • Lenox Wealth Management held 49 shares of Thermo Fisher Scientific worth $18K as of Q2 2020.
  • Lenox Wealth Management bought 35 Thermo Fisher Scientific shares in Q2 2020, an estimated $11.7K.
  • Thermo Fisher Scientific made up 0.01% of Lenox Wealth Management's portfolio in Q2 2020, its #362 holding.
  • Lenox Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 11 quarters since.
  • 1,748 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.